BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 27448786)

  • 1. Human gene therapy: novel approaches to improve the current gene delivery systems.
    Cucchiarini M
    Discov Med; 2016 Jun; 21(118):495-506. PubMed ID: 27448786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety profile of recombinant adeno-associated viral vectors: focus on alipogene tiparvovec (Glybera®).
    Salmon F; Grosios K; Petry H
    Expert Rev Clin Pharmacol; 2014 Jan; 7(1):53-65. PubMed ID: 24308784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five years of vector service for gene therapy.
    Mezzina M; Danos O
    Trends Genet; 2002 Mar; 18(3):118-9. PubMed ID: 11858829
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene therapy of the central nervous system: general considerations on viral vectors for gene transfer into the brain.
    Serguera C; Bemelmans AP
    Rev Neurol (Paris); 2014 Dec; 170(12):727-38. PubMed ID: 25459120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular trafficking, metabolism and toxicity of current gene carriers.
    Kuo WT; Huang HY; Huang YY
    Curr Drug Metab; 2009 Oct; 10(8):885-94. PubMed ID: 20214583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endgame: glybera finally recommended for approval as the first gene therapy drug in the European union.
    Ylä-Herttuala S
    Mol Ther; 2012 Oct; 20(10):1831-2. PubMed ID: 23023051
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene Delivery with Organic Electronic Biomaterials.
    Clancy KFA; Hardy JG
    Curr Pharm Des; 2017; 23(24):3614-3625. PubMed ID: 28699530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress and prospects: prospects of repeated pulmonary administration of viral vectors.
    Sinn PL; Burnight ER; McCray PB
    Gene Ther; 2009 Sep; 16(9):1059-65. PubMed ID: 19641533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Viral Vector-Mediated Gene Therapy for ALS: Challenges and Future Perspectives.
    Ediriweera GR; Chen L; Yerbury JJ; Thurecht KJ; Vine KL
    Mol Pharm; 2021 Jun; 18(6):2142-2160. PubMed ID: 34010004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming innate immune barriers that impede AAV gene therapy vectors.
    Muhuri M; Maeda Y; Ma H; Ram S; Fitzgerald KA; Tai PW; Gao G
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33393506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New cell engineering approaches for cartilage regenerative medicine.
    Cucchiarini M
    Biomed Mater Eng; 2017; 28(s1):S201-S207. PubMed ID: 28372296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent tissue engineering-based advances for effective rAAV-mediated gene transfer in the musculoskeletal system.
    Rey-Rico A; Cucchiarini M
    Bioengineered; 2016 Apr; 7(3):175-88. PubMed ID: 27221233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical translation of gene medicine.
    Wang F; Qin Z; Lu H; He S; Luo J; Jin C; Song X
    J Gene Med; 2019 Jul; 21(7):e3108. PubMed ID: 31246328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of AAV Capsid-Specific T-Cell Responses on Design and Outcome of Clinical Gene Transfer Trials with Recombinant Adeno-Associated Viral Vectors: An Evolving Controversy.
    Ertl HCJ; High KA
    Hum Gene Ther; 2017 Apr; 28(4):328-337. PubMed ID: 28042943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned from lung and liver in-vivo gene therapy: implications for the future.
    van Haasteren J; Hyde SC; Gill DR
    Expert Opin Biol Ther; 2018 Sep; 18(9):959-972. PubMed ID: 30067117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The standpoint of gene therapy programs.
    Romano G
    Drug News Perspect; 2007 Jun; 20(5):335-43. PubMed ID: 17878962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulating the gene-therapy revolution.
    Bender E
    Nature; 2018 Dec; 564(7735):S20-S22. PubMed ID: 30542185
    [No Abstract]   [Full Text] [Related]  

  • 18. Workshop on long-term follow-up of participants in human gene transfer research.
    Nyberg K; Carter BJ; Chen T; Dunbar C; Flotte TR; Rose S; Rosenblum D; Simek SL; Wilson C
    Mol Ther; 2004 Dec; 10(6):976-80. PubMed ID: 16156012
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene transfer to salivary glands.
    Baum BJ; Wellner RB; Zheng C
    Int Rev Cytol; 2002; 213():93-146. PubMed ID: 11837896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAV Vectors: Are They Safe?
    Srivastava A
    Hum Gene Ther; 2020 Jul; 31(13-14):697-699. PubMed ID: 32611206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.